Ann & Robert H Lurie Children's Hospital of Chicago
luriechildrens.orgLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
177
Active
42
Phase 3
7
Total enrollment
40,612
Pipeline matrix
Showing 13 of 13 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Recombinant Zoster Vaccine | — | — | — | — | — | 1 | |
| Combination therapy | — | — | — | — | — | 1 | |
| Trametinib and Nivolumab | — | — | — | — | — | 1 | |
| Dabrafenib, trametinib, nivolumab | — | — | — | — | — | 1 | |
| Tylenol | — | — | — | — | — | 1 | |
| Atropine | — | — | — | — | — | 1 | |
| Cytalux | — | — | — | — | — | 1 | |
| rHSC-DIPGVax | — | — | — | — | — | 1 | |
| Balstilimab | — | — | — | — | — | 1 | |
| Zalifrelimab | — | — | — | — | — | 1 | |
| Empagliflozin 10 MG | — | — | — | — | — | 1 | |
| trimethoprim-sulfamethoxazole | — | — | — | — | — | 1 | |
| Dose | — | — | — | — | — | 1 |
Next readouts
- 2018-12
- 2025-08-31
- 2026-03-13
- 2026-06-01
- 2026-08-31
- 2026-09
- 2027-03-31
- 2027-05
- 2028-12
- 2028-12-31
Top conditions
- Sickle Cell Disease6
- Eosinophilic Esophagitis6
- Leukemia6
- Cancer5
- Sickle Cell Hemoglobin C4
- Sickle Beta Zero Thalassemia4
- Sickle B+ Thalassemia4
- HIV4
Frequently asked questions about Ann & Robert H Lurie Children's Hospital of Chicago
- How many clinical trials does Ann & Robert H Lurie Children's Hospital of Chicago have on ClinicalTrials.gov?
- Ann & Robert H Lurie Children's Hospital of Chicago is listed as the lead sponsor on 177 clinical trials in ClinicalTrials.gov, 42 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Ann & Robert H Lurie Children's Hospital of Chicago's trials are in Phase 3?
- 7 of Ann & Robert H Lurie Children's Hospital of Chicago's trials are in Phase 3, spread across 13 active drug programs.
- What therapeutic areas does Ann & Robert H Lurie Children's Hospital of Chicago focus on?
- Ann & Robert H Lurie Children's Hospital of Chicago's most-studied conditions on ClinicalTrials.gov are Sickle Cell Disease, Eosinophilic Esophagitis, Leukemia, Cancer, Sickle Cell Hemoglobin C.
- When are Ann & Robert H Lurie Children's Hospital of Chicago's next clinical trial readouts?
- Ann & Robert H Lurie Children's Hospital of Chicago has 10 upcoming primary-completion readouts tracked here; the soonest is “Prophylactic Antibiotics or Placebo After Hypospadias Repair”, expected around 2018-12.